Using whole-exome sequencing, the authors identified a recurrent missense mutation (V1092A) in the C-terminal kinase domain of ALPK1 gene in the spiradenomas and spiradenocarcinomas; this mutation activated the NF-κβ pathway in a reporter assay. Here, NFKB1 is linked to benign spiradenoma.